News
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...
Regeneron Pharmaceuticals said on Monday its experimental weight-loss drug combination helped preserve muscle mass in a ...
The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...
18h
Stocktwits on MSNHims & Hers Faces Retail Skepticism After Layoffs, FDA Ban on Compounded WegovyRetail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...
(Reuters) -German packaging and medical equipment maker Gerresheimer on Monday cut its revenue and profit margin guidance for ...
5h
Zacks.com on MSNWhy Novo Nordisk (NVO) is a Top Dividend Stock for Your PortfolioDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes? Let's find out.
In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results